ANRis, Inc.
PrivateLast Round
VC Round
Jul 8, 2024
Total Funding Raised
$1.34M
Company Overview
ANRis, Inc. is a biotechnology company that develops siRNA-based nucleic acid medicines utilizing its proprietary SNPD-siRNA technology to provide precise, personalized treatments for cancer and genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ANRis, Inc. Comparables
Compare ANRis, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| City Therapeutics | 77% | |
| aceRNA Technologies Co., Ltd. | 75% | |
| CLOVERNA Inc. | 72% |
ANRis, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 8, 2024 | ||||
| Seed | Nov 28, 2023 |
ANRis, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| QB Capital | VC Round |
| WASEDA University Ventures | Seed |
| NCB Venture Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 8, 2024
Raised capital from NCB Venture Capital and QB Capital.
- Nov 28, 2023
$1.34M round led by WASEDA University Ventures.
ANRis, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ANRis, Inc.'s valuation, stock price, and market status.
Is ANRis, Inc. a public or private company?
ANRis, Inc. is a private company.
What is the current stock price of ANRis, Inc.?
ANRis, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is ANRis, Inc. worth (valuation)?
Valuation information for ANRis, Inc. is not publicly available.
Can I buy ANRis, Inc. stock?
ANRis, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ANRis, Inc.'s last funding round?
ANRis, Inc.'s most recent funding round was VC Round on July 8, 2024.
Who are the main investors in ANRis, Inc.?
Key investors in ANRis, Inc. include QB Capital, WASEDA University Ventures, NCB Venture Capital.
Will ANRis, Inc. IPO soon?
No public IPO plans have been announced for ANRis, Inc..
How can I track ANRis, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ANRis, Inc.'s secondary market activity and sign up for updates.